Notably, SP exhibits high affinity for NK‐1R, leading to its designation as the “SP receptor.” Importantly, the SP/NK‐1R interaction has been shown to drive glioblastoma cell survival, proliferation, migration, and angiogenesis while having minimal effects on healthy cells, making it an attractive therapeutic target. Here, TACR1 is linked to glioblastoma.